Abstract
Damage-associated molecular patterns (DAMPs) comprise intracellular molecules characterized by the ability to reach the extracellular environment, where they prompt inflammation and tissue repair. The high-mobility box group 1 (HMGB1) protein is a prototypic DAMP and is highly conserved in evolution. HMGB1 is released upon cell and tissue necrosis and is actively produced by immune cells. Evidence suggests that HMGB1 acts as a key molecule of innate immunity, downstream of persistent tissue injury, orchestrating inflammation, stem cell recruitment/activation, and eventual tissue remodeling.
Similar content being viewed by others
References
Abdulahad DA, Westra J, Limburg PC, Kallenberg CG, Bijl M (2010) HMGB1 in systemic lupus erythematosus: its role in cutaneous lesions development. Autoimmun Rev 9:661-665
Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M et al (2005) The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest 115:1267–1274
Andersson U, Harris HE (2010) The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim Biophys Acta 1799:141–148
Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H et al (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565–570
Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A et al (2007a) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13:1050–1059
Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R et al (2007b) The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev 220:47–59
Banchereau J, Pascual V (2006) Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25:383–392
Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS (2006) The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 291:C1318–C1325
Bianchi ME (2009) HMGB1 loves company. J Leukoc Biol 86:573–576
Bianchi ME, Manfredi A (2004) Chromatin and cell death. Biochim Biophys Acta 1677:181–186
Bianchi ME, Manfredi AA (2007) High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 220:35–46
Bianchi ME, Manfredi AA (2009) Immunology. Dangers in and out. Science 323:1683–1684
Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A et al (2003) Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22:5551–5560
Bondanza A, Zimmermann VS, Dell'Antonio G, Dal Cin E, Balestrieri G, Tincani A et al (2004) Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum 50:1549–1560
Bondanza A, Rovere-Querini P, Zimmermann VS, Balestrieri G, Tincani A, Sabbadini MG et al (2007) Requirement for dendritic cells in the establishment of anti-phospholipid antibodies. Autoimmunity 40:302–306
Campana L, Bosurgi L, Rovere-Querini P (2008) HMGB1: a two-headed signal regulating tumor progression and immunity. Curr Opin Immunol 20:518–523
Campana L, Bosurgi L, Bianchi ME, Manfredi AA, Rovere-Querini P (2009) Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J Leukoc Biol 86:609–615
Carta S, Castellani P, Delfino L, Tassi S, Vene R, Rubartelli A (2009) DAMPs and inflammatory processes: the role of redox in the different outcomes. J Leukoc Biol 86:549–555
Catena R, Escoffier E, Caron C, Khochbin S, Martianov I, Davidson I (2009) HMGB4, a novel member of the HMGB family, is preferentially expressed in the mouse testis and localizes to the basal pole of elongating spermatids. Biol Reprod 80:358–366
Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P et al (2007) Highmobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 100:204–212
Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13:851–856
Chen GY, Tang J, Zheng P, Liu Y (2009) CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323:1722–1725
Chung HW, Lee SG, Kim H, Hong DJ, Chung JB, Stroncek D, Lim JB (2009) Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer. J Transl Med 7:38
Crikis S, Zhang XM, Dezfouli S, Dwyer KM, Murray-Segal LM, Salvaris E et al (2010) Antiinflammatory and anticoagulant effects of transgenic expression of human thrombomodulin in mice. Am J Transplant 10:242–250
Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP et al (2005a) Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 174:7506–7515
Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME, Rovere-Querini P (2005b) HMGB1: guiding immunity from within. Trends Immunol 26:381–387
Dumitriu IE, Baruah P, Bianchi ME, Manfredi AA, Rovere-Querini P (2005c) Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur J Immunol 25:25
Dumitriu IE, Bianchi ME, Bacci M, Manfredi AA, Rovere-Querini P (2007) The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol 81:84–91
Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME et al (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 3:995–1001
Germani A, Limana F, Capogrossi MC (2007) Pivotal advances: high-mobility group box 1 protein—a cytokine with a role in cardiac repair. J Leukoc Biol 81:41–45
Hoppe G, Talcott KE, Bhattacharya SK, Crabb JW, Sears JE (2006) Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp Cell Res 312:3526–3538
Hreggvidsdottir HS, Ostberg T, Wahamaa H, Schierbeck H, Aveberger AC, Klevenvall L et al (2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 86:655–662
Ito I, Fukazawa J, Yoshida M (2007) Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J Biol Chem 282:16336–16344
Ito T, Kawahara K, Okamoto K, Yamada S, Yasuda M, Imaizumi H et al (2008) Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes. Arterioscler Thromb Vasc Biol 28:1825–1830
Ivanov S, Dragoi AM, Wang X, Dallacosta C, Louten J, Musco G et al (2007) A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110:1970–1981
Janeway CA Jr (1992) The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 13:11–16
Jiang W, Bell CW, Pisetsky DS (2007) The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid. J Immunol 178:6495–6503
Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA (2008) Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high mobility group box-1 protein. Immunity 29:21–32
Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A (2008) HMGB1: endogenous danger signaling. Mol Med 14:476–484
Knapp S, Muller S, Digilio G, Bonaldi T, Bianchi ME, Musco G (2004) The long acidic tail of high mobility group box 1 (HMGB1) protein forms an extended and flexible structure that interacts with specific residues within and between the HMG boxes. Biochemistry 43:11992–11997
Kornblit B, Munthe-Fog L, Madsen HO, Strøm J, Vindeløv L, Garred P (2008) Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Crit Care 12:R83
Kornblit B, Masmas T, Petersen SL, Madsen HO, Heilmann C, Schejbel L, Sengeløv H, Müller K, Garred P, Vindeløv L (2010) Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 16:239–252
Koutsi A, Papapanagiotou A, Papavassiliou AG (2008) Thrombomodulin: from haemostasis to inflammation and tumourigenesis. Int J Biochem Cell Biol 40:1669–1673
Krynetskaia NF, Phadke MS, Jadhav SH, Krynetskiy EY (2009) Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage. Mol Cancer Ther 8:864–872
Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF et al (2004) TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 5:190–198
Lee D, Kwon JH, Kim EH, Kim ES, Choi KY (2010) HMGB2 stabilizes p53 by interfering with E6/E6AP-mediated p53 degradation in human papillomavirus-positive HeLa cells. Cancer Lett 292:125–132
Li J, Kokkola R, Tabibzadeh S, Yang R, Ochani M, Qiang X et al (2003) Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med 9:37–45
Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G et al (2005) Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 97:e73–e83
Liu Y, Chen GY, Zheng P (2009) CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns. Trends Immunol 30:557–561
Lolmede K, Campana L, Vezzoli M, Bosurgi L, Tonlorenzi R, Clementi E et al (2009) Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J Leukoc Biol 85:779–787
Lotfi R, Herzog GI, DeMarco RA, Beer-Stolz D, Lee JJ, Rubartelli A et al (2009) Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells. J Immunol 183:5023–5031
Lotze MT, Deisseroth A, Rubartelli A (2007) Damage associated molecular pattern molecules. Clin Immunol 124:1–4
Mahoney JA, Rosen A (2005) Apoptosis and autoimmunity. Curr Opin Immunol 17:583–588
Manfredi AA, Rovere-Querini P (2010) The mitochondrion—a Trojan horse that kicks off inflammation? N Engl J Med 362:2132–2134
Manfredi AA, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A (2008a) Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol 20:538–544
Manfredi AA, Capobianco A, Esposito A, De Cobelli F, Canu T, Monno A et al (2008b) Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol 180:2270–2275
Manfredi AA, Capobianco A, Bianchi ME, Rovere-Querini P (2009) Regulation of dendriticand T-cell fate by injury-associated endogenous signals. Crit Rev Immunol 29:69–86
Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM et al (2010) A causative role of Toll-like receptor 4 (TLR4) activation by high mobility group box 1 (HMGB1) protein in ictogenesis. Nat Med 16:413–419
Marshak-Rothstein A, Rifkin IR (2007) Immunologically active autoantigens: the role of tolllike receptors in the development of chronic inflammatory disease. Annu Rev Immunol 25:419–441
Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301–305
Maugeri N, Rovere-Querini P, Baldini M, Sabbadini MG, Manfredi AA (2009) Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis. Clin Exp Immunol 156:395–404
Messmer D, Yang H, Telusma G, Knoll F, Li J, Messmer B et al (2004) High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 173:307–313
Mittal D, Saccheri F, Vénéreau E, Pusterla T, Bianchi ME, Rescigno M (2010) TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J 29:2242-2252
Muller S, Scaffidi P, Degryse B, Bonaldi T, Ronfani L, Agresti A et al (2001) New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J 20:4337–4340
Muller S, Ronfani L, Bianchi ME (2004) Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J Intern Med 255:332–343
Munoz LE, Janko C, Grossmayer GE, Frey B, Voll RE, Kern P et al (2009) Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum 60:1733–1742
Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M (2010a) The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 6:280–289
Munoz L, Lauber K, Schiller M, Manfredi AA, Herrmann M (2010b) Defective clearance of apoptotic cells—role in the etiology and pathogenesis of systemic autoimmunity. Nat Rev Rheumatol 6:280–289
Nagato M, Okamoto K, Abe Y, Higure A, Yamaguchi K (2009) Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia. Crit Care Med 37:2181–2186
Nathan C (2002) Points of control in inflammation. Nature 420:846–852
Oh YJ, Youn JH, Ji Y, Lee SE, Lim KJ, Choi JE et al (2009) HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism. J Immunol 182:5800–5809
Oppenheim JJ, Yang D (2005) Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17:359–365
Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E et al (2007) A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 26:1129–1139
Palumbo R, Sampaolesi M, De Marchis F, Tonlorenzi R, Colombetti S, Mondino A et al (2004) Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 164:441–449
Palumbo R, Galvez BG, Pusterla T, De Marchis F, Cossu G, Marcu KB et al (2007) Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NFkappaB activation. J Cell Biol 179:33–40
Palumbo R, De Marchis F, Pusterla T, Conti A, Alessio M, Bianchi ME (2009) Src family kinases are necessary for cell migration induced by extracellular HMGB1. J Leukoc Biol 86:617–623
Penzo M, Molteni R, Suda T, Samaniego S, Raucci A, Habiel DM et al (2010) Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis. J Immunol 184:4497–4509
Pisetsky DS (2010) HMGB1: a dangerous player in lupus pathogenesis. J Rheumatol 37:689–691
Pisetsky DS, Fairhurst AM (2007) The origin of extracellular DNA during the clearance of dead and dying cells. Autoimmunity 40:281–284
Pisetsky DS, Ronnblom L (2009) Systemic lupus erythematosus: a matter of life and death. Arthritis Rheum 60:1567–1570
Pisetsky DS, Erlandsson-Harris H, Andersson U (2008) High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther 10:209
Pulendran B, Palucka K, Banchereau J (2001) Sensing pathogens and tuning immune responses. Science 293:253–256
Pusterla T, De Marchis F, Palumbo R, Bianchi ME (2009) High mobility group B2 is secreted by myeloid cells and has mitogenic and chemoattractant activities similar to high mobility group B1. Autoimmunity 42:308–310
Randolph GJ, Angeli V, Swartz MA (2005) Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 5:617–628
Raucci A, Palumbo R, Bianchi ME (2007) HMGB1: a signal of necrosis. Autoimmunity 40:285–289
Rauvala H, Rouhiainen A (2010) Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors. Biochim Biophys Acta 1799:164–170
Rock KL, Kono H (2008) The inflammatory response to cell death. Annu Rev Pathol 3:99–126
Rouhiainen A, Imai S, Rauvala H, Parkkinen J (2000) Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost 84:1087–1094
Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H (2007) Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol 81:49–58
Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M et al (2004) HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 5:825–830
Rovere-Querini P, Castiglioni MT, Sabbadini MG, Manfredi AA (2007) Signals of cell death and tissue turnover during physiological pregnancy, pre-eclampsia, and autoimmunity. Autoimmunity 40:290–294
Rubartelli A, Sitia R (2009) Stress as an intercellular signal: the emergence of stress-associated molecular patterns (SAMP). Antioxid Redox Signal 11:2621–2629
Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191–195
Semino C, Angelini G, Poggi A, Rubartelli A (2005) NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106:609–616
Sessa L, Bianchi ME (2007) The evolution of high mobility group box (HMGB) chromatin proteins in multicellular animals. Gene 387:133–140
Sha Y, Zmijewski J, Xu Z, Abraham E (2008) HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 180:2531–2537
Shaw TJ, Martin P (2009) Wound repair at a glance. J Cell Sci 122:3209–3213
Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ (2010) HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28:367–388
Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, Im J et al (2009) RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 7:17
Stros M (2010) HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta 1799:101–113
Susa Y, Masuda Y, Imaizumi H, Namiki A (2009) Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis. Crit Care Med 37:2619–2624
Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE et al (2010) HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene (in press)
Taniguchi N, Carames B, Ronfani L, Ulmer U, Komiya S, Bianchi ME et al (2009) Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis. Proc Natl Acad Sci USA 106:1181-1186
Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H et al (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8:487–496
Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT et al (2005) The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201:1135–1143
Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X et al (2007) HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 204(12):2913–2923
Ugrinova I, Pashev IG, Pasheva EA (2009) Nucleosome binding properties and core-modeling activities of native and in vivo acetylated HMGB-1 and HMGB-2 proteins. Biochemistry 48:6502–6507
Ulloa L, Messmer D (2006) High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 28:28
Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F et al (2008) Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 205:3007–3018
Urbonaviciute V, Meister S, Furnrohr BG, Frey B, Guckel E, Schett G et al (2009) Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis. Autoimmunity 42:305–307
Vakkila J, Lotze MT (2004) Inflammation and necrosis promote tumour growth. Nat Rev Immunol 4:641–648
Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251
Wixted WE, Kitson C, Colebrook JC, Roberts EJ, Fox SM, Kou JP et al (2010) A model to identify novel targets involved in oxidative stress-induced apoptosis in human lung epithelial cells by RNA interference. Toxicol In Vitro 24:310–318
Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H et al (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462:99–103
Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ (2007) High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 81:59–66
Yang D, Tewary P, Rosa G de la, Wei F, Oppenheim JJ (2010) The alarmin functions of high-mobility group proteins. Biochim Biophys Acta 1799:157–163
Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J et al (2010) A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 107:11942-11947
Youn JH, Shin JS (2006) Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 177:7889–7897
Youn JH, Oh YJ, Kim ES, Choi JE, Shin JS (2008) High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J Immunol 180:5067–5074
Yuk JM, Yang CS, Shin DM, Kim KK, Lee SK, Song YJ et al (2009) A dual regulatory role of apurinic/apyrimidinic endonuclease 1/redox factor-1 in HMGB1-induced inflammatory responses. Antioxid Redox Signal 11:575–588
Zeh HJ 3rd, Lotze MT (2005) Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother 28:1–9
Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W et al (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104–107
Acknowledgements
The work in the authors’ laboratories is supported by the Ministero della Salute, by the AIRC (Associazione Italiana per la Ricerca sul Cancro) and by the MIUR.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Castiglioni, A., Canti, V., Rovere-Querini, P. et al. High-mobility group box 1 (HMGB1) as a master regulator of innate immunity. Cell Tissue Res 343, 189–199 (2011). https://doi.org/10.1007/s00441-010-1033-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-010-1033-1